Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

Inhibition of Small-Conductance Ca²⁺-Activated K⁺ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

Circ Arrhythm Electrophysiol. 2017 Oct;10(10):e005776. doi: 10.1161/CIRCEP.117.005776.

¹ From the Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, The Netherlands (J.H.); and Institute of Pharmacology, West German Heart and Vascular Center, School of Medicine, University Duisburg-Essen, Germany (D.D.).
² From the Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, The Netherlands (J.H.); and Institute of Pharmacology, West German Heart and Vascular Center, School of Medicine, University Duisburg-Essen, Germany (D.D.). dobromir.dobrev@uk-essen.de.

No abstract available

Keywords: Editorials; atrial fibrillation; catheter ablation; morbidity; prevalence; stroke.